Stifel Maintains Hold on Core Laboratories, Raises Price Target to $22
Portfolio Pulse from Benzinga Newsdesk
Stifel analyst Stephen Gengaro maintains a Hold rating on Core Laboratories (NYSE:CLB) and raises the price target from $18 to $22.
July 26, 2024 | 2:59 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Stifel analyst Stephen Gengaro maintains a Hold rating on Core Laboratories and raises the price target from $18 to $22.
The raised price target from $18 to $22 indicates a positive outlook from the analyst, which could lead to a short-term increase in the stock price. However, the Hold rating suggests a cautious approach, balancing the positive impact.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100